vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and BRC Group Holdings, Inc. (RILY). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $188.3M, roughly 1.3× BRC Group Holdings, Inc.). BRC Group Holdings, Inc. runs the higher net margin — 47.9% vs -35.0%, a 83.0% gap on every dollar of revenue. On growth, BRC Group Holdings, Inc. posted the faster year-over-year revenue change (-21.9% vs -23.6%). Over the past eight quarters, BRC Group Holdings, Inc.'s revenue compounded faster (-15.4% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
CCRN vs RILY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $188.3M |
| Net Profit | $-82.9M | $90.3M |
| Gross Margin | — | 79.5% |
| Operating Margin | -30.2% | 32.3% |
| Net Margin | -35.0% | 47.9% |
| Revenue YoY | -23.6% | -21.9% |
| Net Profit YoY | -2109.7% | 1710.8% |
| EPS (diluted) | $-2.56 | $2.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $188.3M | ||
| Q3 25 | $250.1M | $215.3M | ||
| Q2 25 | $274.1M | $188.2M | ||
| Q1 25 | $293.4M | $197.2M | ||
| Q4 24 | $309.9M | $241.0M | ||
| Q3 24 | $315.1M | $225.5M | ||
| Q2 24 | $339.8M | $256.0M | ||
| Q1 24 | $379.2M | $263.4M |
| Q4 25 | $-82.9M | $90.3M | ||
| Q3 25 | $-4.8M | $91.1M | ||
| Q2 25 | $-6.7M | $139.5M | ||
| Q1 25 | $-490.0K | $-10.0M | ||
| Q4 24 | $-3.8M | $-5.6M | ||
| Q3 24 | $2.6M | $-284.4M | ||
| Q2 24 | $-16.1M | $-433.6M | ||
| Q1 24 | $2.7M | $-49.2M |
| Q4 25 | — | 79.5% | ||
| Q3 25 | 20.4% | 83.7% | ||
| Q2 25 | 20.4% | 81.3% | ||
| Q1 25 | 20.0% | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | 20.4% | 82.1% | ||
| Q2 24 | 20.8% | 84.5% | ||
| Q1 24 | 20.4% | 85.3% |
| Q4 25 | -30.2% | 32.3% | ||
| Q3 25 | -2.4% | 30.4% | ||
| Q2 25 | -2.1% | 5.7% | ||
| Q1 25 | -0.3% | -31.2% | ||
| Q4 24 | -1.1% | -69.2% | ||
| Q3 24 | 0.9% | -36.4% | ||
| Q2 24 | -5.7% | -90.8% | ||
| Q1 24 | 0.8% | -6.1% |
| Q4 25 | -35.0% | 47.9% | ||
| Q3 25 | -1.9% | 42.3% | ||
| Q2 25 | -2.4% | 74.1% | ||
| Q1 25 | -0.2% | -5.1% | ||
| Q4 24 | -1.2% | -2.3% | ||
| Q3 24 | 0.8% | -126.1% | ||
| Q2 24 | -4.7% | -169.4% | ||
| Q1 24 | 0.7% | -18.7% |
| Q4 25 | $-2.56 | $2.78 | ||
| Q3 25 | $-0.15 | $2.91 | ||
| Q2 25 | $-0.20 | $4.50 | ||
| Q1 25 | $-0.02 | $-0.39 | ||
| Q4 24 | $-0.13 | $-0.01 | ||
| Q3 24 | $0.08 | $-9.39 | ||
| Q2 24 | $-0.47 | $-14.35 | ||
| Q1 24 | $0.08 | $-1.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $226.6M |
| Total DebtLower is stronger | — | $1.4B |
| Stockholders' EquityBook value | $322.8M | $-171.5M |
| Total Assets | $449.0M | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $226.6M | ||
| Q3 25 | $99.1M | $184.2M | ||
| Q2 25 | $81.2M | $267.4M | ||
| Q1 25 | $80.7M | $138.3M | ||
| Q4 24 | $81.6M | $146.9M | ||
| Q3 24 | $64.0M | $159.2M | ||
| Q2 24 | $69.6M | $236.9M | ||
| Q1 24 | $5.2M | $190.7M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $322.8M | $-171.5M | ||
| Q3 25 | $408.1M | $-260.5M | ||
| Q2 25 | $412.2M | $-351.7M | ||
| Q1 25 | $418.2M | $-496.8M | ||
| Q4 24 | $419.0M | $-488.2M | ||
| Q3 24 | $424.7M | $-497.6M | ||
| Q2 24 | $433.3M | $-218.3M | ||
| Q1 24 | $462.4M | $228.4M |
| Q4 25 | $449.0M | $1.7B | ||
| Q3 25 | $538.2M | $1.7B | ||
| Q2 25 | $553.8M | $1.5B | ||
| Q1 25 | $576.2M | $1.5B | ||
| Q4 24 | $589.3M | $1.8B | ||
| Q3 24 | $597.4M | $2.2B | ||
| Q2 24 | $602.9M | $3.2B | ||
| Q1 24 | $648.4M | $5.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $26.2M |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | 0.29× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $26.2M | ||
| Q3 25 | $20.1M | $-60.6M | ||
| Q2 25 | $4.2M | $-25.6M | ||
| Q1 25 | $5.7M | $184.0K | ||
| Q4 24 | $24.2M | $-2.7M | ||
| Q3 24 | $7.5M | $19.5M | ||
| Q2 24 | $82.4M | $111.5M | ||
| Q1 24 | $6.0M | $135.4M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | -0.66× | ||
| Q2 25 | — | -0.18× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
